Prostate cancer: open trials in Hungary

10 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét · Szent Lazar Megyei Korhaz, Salgotarjan
Registry updated 2026-11-05
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Orszagos Onkologiai Intezet, Budapest XII · Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz, Győr · Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz, Miskolc · Nograd Varmegyei Szent Lazar Korhaz, Salgótarján
Registry updated 2026-10-30
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét
Registry updated 2026-10-26
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Semmelweis University, Budapest · Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz, Miskolc · Szent Lazar Megyei Korhaz, Salgotarjan
Registry updated 2026-10-20
NCT07365995
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · BioNTech SE
Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét · Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz, Miskolc · University of Pecs, Pécs
Registry updated 2026-10-16
NCT07711002
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Trial Treatment · Phase 3 · AstraZeneca
Semmelweis University, Budapest · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Orszagos Onkologiai Intezet, Budapest XII · University of Pecs, Pécs · University of Szeged, Szeged
Registry updated 2026-10-15
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
Semmelweis University, Budapest · Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz, Győr · Bekes Varmegyei Koezponti Korhaz, Gyula · Zala Varmegyei Szent Rafael Korhaz, Zalaegerszeg
Registry updated 2026-10-14
NCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Semmelweis University, Budapest · Semmelweis University, Budapest VIII · Orszagos Onkologiai Intezet, Budapest XII · University of Szeged, Szeged
Registry updated 2026-09-29
NCT06458712
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Trial Treatment · Phase 1 · Duke Street Bio Ltd
Orszagos Onkologiai Intezet, Budapest XII
Registry updated 2026-09-02

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error